ReviR Therapeutics
PrivateLast Round
Grant
Nov 20, 2025
Total Funding Raised
$58.6M
Company Overview
ReviR Therapeutics is a biotechnology company focused on developing RNA therapeutics to address cancer, rare genetic disorders, and infectious diseases through an AI-driven platform that facilitates the discovery of RNA-targeting treatments for millions of patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReviR Therapeutics Comps
Public and private peers based on sector, stage, and business model.
ReviR Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 20, 2025 | ||||
| Series A | Jul 26, 2024 | ||||
| Seed | Jan 17, 2022 |
ReviR Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series A, Seed |
| Yael Capital | Series A |
| Tiantu Capital | Seed |
| Lapam Capital | Series A |
| Sky9 Capital | Seed |
| 5Y Capital | Series A, Seed |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
Raised $4.6M in grant funding.
ReviR Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ReviR Therapeutics's valuation, stock price, and market status.
